We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+1.52%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$486B
AUM Growth
+$2.12B
Cap. Flow
+$867M
Cap. Flow %
0.18%
Top 10 Hldgs %
13.96%
Holding
2,615
New
76
Increased
1,051
Reduced
777
Closed
79

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.76B
2
CI icon
Cigna
CI
+$1.44B
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.26B
4
OXY icon
Occidental Petroleum
OXY
+$763M
5
DHR icon
Danaher
DHR
+$762M

Top Sells

Rank Stock Value
1
PCYC
PHARMACYCLICS INC
PCYC
+$2.46B
2
WYNN icon
Wynn Resorts
WYNN
+$1.11B
3
NFLX icon
Netflix
NFLX
+$1.03B
4
PCP
PRECISION CASTPARTS CORP
PCP
+$975M
5
TWTR
Twitter, Inc.
TWTR
+$909M

Sector Composition

Rank Sector Weight
1 Healthcare 22.87%
2 Financials 13.64%
3 Consumer Discretionary 13.54%
4 Industrials 10.67%
5 Technology 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACTA
2351
DELISTED
Actua Corp
ACTA
$181K ﹤0.01%
12,700
– –
OPCH icon
2352
Option Care Health
OPCH
$3.57B
$180K ﹤0.01%
12,400
– –
KRNY icon
2353
Kearny Financial
KRNY
$600M
$179K ﹤0.01%
16,012
-1
-0% -$10
HHS icon
2354
Harte-Hanks
HHS
$18.6M
$177K ﹤0.01%
2,975
+300
+11% +$20.2K
RT
2355
DELISTED
Ruby Tuesday Georgia
RT
$177K ﹤0.01%
28,200
– –
IMNN icon
2356
Imunon
IMNN
$6.77M
$176K ﹤0.01%
27
+13
+93% +$92.3K
KE
2357
Kimball Electronics
KE
$606M
$175K ﹤0.01%
11,992
– –
PCTI
2358
DELISTED
PCTEL, Inc. Common Stock
PCTI
$175K ﹤0.01%
24,400
+800
+3% +$6K
CMO
2359
DELISTED
Capstead Mortgage Corp.
CMO
$173K ﹤0.01%
15,600
– –
STRR
2360
DELISTED
Star Equity Holdings
STRR
$172K ﹤0.01%
792
– –
QUMU
2361
DELISTED
Qumu Corp.
QUMU
$171K ﹤0.01%
20,750
– –
CENX icon
2362
Century Aluminum
CENX
$4.77B
$170K ﹤0.01%
16,343
– –
FRM
2363
DELISTED
FURMANITE CORPORATION COM
FRM
$170K ﹤0.01%
20,900
– –
REFR icon
2364
Research Frontiers
REFR
$16.8M
$169K ﹤0.01%
31,600
– –
PLAB icon
2365
Photronics
PLAB
$1.97B
$168K ﹤0.01%
17,660
– –
QMCO icon
2366
Quantum Corp
QMCO
$864M
$166K ﹤0.01%
618
– –
PFBI
2367
DELISTED
Premier Financial Bancorp
PFBI
$166K ﹤0.01%
14,732
– –
RDEN
2368
DELISTED
ELIZABETH ARDEN INC
RDEN
$166K ﹤0.01%
11,650
– –
RFP
2369
DELISTED
Resolute Forest Products Inc.
RFP
$164K ﹤0.01%
14,600
– –
AORT icon
2370
Artivion
AORT
$1.4B
$163K ﹤0.01%
14,450
– –
CIA icon
2371
Citizens
CIA
$199M
$163K ﹤0.01%
21,833
– –
TPLM
2372
DELISTED
Triangle Petroleum Corporation
TPLM
$163K ﹤0.01%
32,400
– –
HBIO icon
2373
Harvard Bioscience
HBIO
$27.8M
$161K ﹤0.01%
2,820
– –
EXTR icon
2374
Extreme Networks
EXTR
$3.2B
$159K ﹤0.01%
59,000
– –
ENT
2375
DELISTED
Global Eagle Entertainment Inc.
ENT
$158K ﹤0.01%
484
– –
93 94
95
96 97

Similar funds

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

T. Rowe Price Associates's Q2 2015 Portfolio in Review

As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
  • T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
  • T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
  • T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
  • T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
  • T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
  • T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.

Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.